Towards an optimal TRIPS-compliant industrial policy for the pharmaceutical industry in Bangladesh
Files
Date
2013
Authors
Ala, M.U.
Editors
Sullivan, H.
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Conference paper
Citation
Public Policy in the 'Asian Century' conference, 2013 / Sullivan, H. (ed./s)
Statement of Responsibility
Conference Name
Public Policy in the 'Asian Century' conference (9 Dec 2012 - 10 Dec 2012 : Melbourne, Australia)
Abstract
Since 1982, under a protective regulatory regime, Bangladesh has attained self-sufficiency in off-patent drugs. Of significance, all LDCs including Bangladesh need to implement the Agreement on Trade Related Intellectual Property Rights (TRIPS) of the WTO in 2016. Thisregulatory change warrantsenhanced technology and R&D adoption to improve firms’ competitiveness. Using data obtained from 94 pharmaceutical companies through a questionnaire survey, this study provides an empirical analysis of firm-level TRIPS-related vulnerability facing the Bangladeshi pharmaceutical sector. Ifind that R&D-related and international competitiveness-related vulnerabilities are the most important types of vulnerability. A vulnerability-based classification using cluster analysis reveals that the least vulnerable firms have comparatively higher involvement in independentand collaborative R&D activities.However, at the industry level, the inter-firm and firm-academia/institution collaboration is significantly low. Thestudy underlines the importance of careful policy intervention to providesustained institutional support to create incentives for multidimensional R&D collaboration,including public-private partnerships.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2013 The Author